TRANSSEPTAL NEEDLE, BRK SERIES
Report
- Report Number
- 3005188751-2011-00168
- Event Type
- Injury
- Date Received
- September 19, 2011
- Date of Event
- September 1, 2011
- Report Date
- September 1, 2011
- Manufacturer
- ST. JUDE MEDICAL AF DIVISION
- Product Code
- DRC
- PMA / PMN Number
- K072278
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WI, US
- Reporter Occupation
- PHYSICIAN
Narratives
WE WERE UNABLE TO EVALUATE THE PRODUCT INVOLVED IN THIS INCIDENT SINCE NO COMPONENTS OF THE DEVICE WERE RETURNED FOR ANALYSIS. A DHR REVIEW WAS NOT POSSIBLE AS THE SERIAL/ LOT NUMBER IS UNK. THE ROOT CAUSE CLASSIFICATION IS CONSISTENT WITH ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED.
IT WAS REPORTED THAT DURING AN ATRIAL FIBRILLATION PROCEDURE, A CARDIAC PERFORATION IN THE LEFT ATRIUM OCCURRED. THE PHYSICIAN ADVANCED A BRK-1 NEEDLE THROUGH AN AGILIS SHEATH AND WAS ATTEMPTING TO MAKE A TRANSSEPTAL PUNCTURE WHEN THE PERFORATION OF THE LEFT ATRIUM OCCURRED. A DUO DECA CATHETER WAS IN THE RIGHT ATRIUM AND A SUPREME 5F QUAD JSN DIAGNOSTIC CATHETER WAS IN THE RIGHT VENTRICLE. A THERAPY COOL PATH CATHETER WAS THEN ADVANCED AND WAS BEING USED TO ISOLATE THE LEFT PULMONARY VEINS. THE PERFORATION WAS NOTED AS THE PT WAS BEING ANTICOAGULATED AND A DROP IN BLOOD PRESSURE WAS NOTED. THE PROCEDURE WAS NOT COMPLETED AND HAS NOT BEEN SCHEDULED AT THE TIME OF THE REPORTING. THE PT HAS RECOVERED AND IS STABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TRANSSEPTAL NEEDLE, BRK SERIES | BRK NEEDLE | DRC | ST. JUDE MEDICAL AF DIVISION | UNK | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 68 YR | Required Intervention | SUPREME 5FR QUAD JSN DIAGNOSTIC CATHETER LOT# UNK| BOSTON SCIENTFIC DOU DECA CATHETER LOT # UNK| THERAPY COOLPATH CATHETER LOT NUMBER UNK| AGILIS SHEATH LOT NUMBER UNK| WORKMATE RECORDING SYSTEM, CPU (B)(4) |